HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transtentorial herniation caused by an intracranial mass lesion following high-dose methotrexate.

Abstract
A patient with intracranial osteosarcoma that arose 16 years after radiation therapy for hereditary retinoblastoma developed fatal cerebral edema and brainstem herniation after she received a single dose of intravenous methotrexate. Autopsy demonstrated extensive necrosis of the tumor mass, as well as necrotizing vascular damage within the neoplasm. Although high-dose methotrexate has been shown to be useful in the treatment of primary osteogenic sarcoma, the tumoricidal effects of therapy appear to have caused a fatal rise in intracranial pressure.
AuthorsB Villareal, L G Baum, H V Vinters, S A Feig
JournalThe American journal of pediatric hematology/oncology (Am J Pediatr Hematol Oncol) Vol. 12 Issue 2 Pg. 215-9 ( 1990) ISSN: 0192-8562 [Print] United States
PMID2378415 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Methotrexate
Topics
  • Adolescent
  • Combined Modality Therapy
  • Encephalocele (etiology)
  • Eye Neoplasms (drug therapy, radiotherapy, surgery)
  • Female
  • Humans
  • Infusions, Intravenous (adverse effects)
  • Intracranial Pressure
  • Methotrexate (adverse effects)
  • Necrosis
  • Neoplasms, Multiple Primary
  • Neoplasms, Radiation-Induced (complications, drug therapy)
  • Orbital Neoplasms (complications, drug therapy)
  • Osteosarcoma (complications, drug therapy)
  • Retinoblastoma (drug therapy, radiotherapy, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: